2B78

iShares Healthcare Innovation UCITS ETF USD (Acc)

ETFs & Funds · EUR · F

2B78ETF

Price

€7.632

+1.67%

Cap

Earnings

30d Trend

+0.5%

2B78
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

41% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level53
Momentum22
Technical52
Fund Quality58
Cost Efficiency40

Raw weighted: 43×Macro 0.99 (1%)=43

RISK

53/100
90d Volatility
41.4%High
ATR %
1.7%Normal
Max Drawdown (1Y)
-26.8%Normal

MOMENTUM

22/100
6-1M Momentum
-22.2%Negative
1M Return
+1.2%Stable

TECHNICAL

52/100
RSI (14)
51.5Neutral
MACD
+0.08Bullish momentum
Bollinger Band
63%Mid-range
Trend Quality (KER)
0.078Noisy/choppy

FUND QUALITY

58/100
Replication
PhysicalHolds actual assets
Holdings
30 positionsConcentrated
Domicile
USADomestic
Yield
0.00% (Distributing)Growth-focused

COST EFFICIENCY

40/100
Expense Ratio
0.68%Moderate
Fund Size (AUM)
$16MMicro (closure risk)

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months51
3-12 months21
1-5+ years48

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate iShares Healthcare Innovation UCITS ETF USD (Acc) at 43/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fund quality at 58/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+1.2%

3 MONTHS

12 MONTHS

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Fund Quality (58) and Technical (52) are the primary strengths. I note that momentum is the weakest area at 22/100 — this warrants monitoring. Historical volatility is elevated at 41%. I classify this as a speculative position — elevated volatility at 41% and asymmetric payoff potential define the opportunity.

speculativeScore: 43/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.